CAI
Caris Life Sciences, Inc.
27.50$
-9.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q3 21 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 7.1% | 7.4% | – | – | – | 62.8% | 58.7% | 87.3% | 86.8% | 88.6% | 87.2% | 86.0% | |
| 1.3% | 1.4% | – | – | – | 18.6% | 10.7% | 75.3% | 76.5% | 70.9% | 70.6% | 56.2% | |
| 1.3% | 1.4% | – | – | – | 19.2% | 11.5% | 75.5% | 76.7% | 71.1% | 70.8% | 64.5% | |
| 5.6% | 5.8% | – | – | – | 25.7% | 27.5% | 5.3% | 2.7% | 10.0% | 7.8% | 9.5% | |
| – | – | – | – | – | 11.5% | 12.5% | 4.3% | 5.0% | 5.7% | 6.6% | 10.1% | |
| – | – | – | – | – | 5.6% | 6.6% | 2.0% | 2.0% | 1.7% | 1.7% | 1.6% | |
| 74.4% | 75.5% | – | – | – | 180.6% | 991.6% | 52.6% | 51.4% | 48.7% | 48.9% | 51.9% | |
| 15.8% | 10.4% | – | – | – | 48.1% | 55.7% | 9.4% | 8.7% | 11.3% | 12.4% | 15.6% | |
| 3.9% | 5.0% | – | – | – | 19.3% | 22.7% | 0.8% | 0.7% | 0.0% | 0.5% | 0.5% | |
| 0.1% | 0.1% | – | – | – | 8.1% | 8.3% | 3.0% | 2.9% | 3.5% | 6.0% | 7.0% | |
| – | – | – | – | – | – | 108.6% | 39.1% | 38.2% | 33.6% | 32.8% | 32.0% | |
| 25.6% | 24.5% | – | – | – | -80.6% | -891.6% | 47.4% | 48.6% | 51.3% | 51.1% | 48.1% | |
| 19.0% | 18.6% | – | – | – | -719.2% | -885.9% | -278.0% | -267.2% | -226.4% | -219.3% | -207.4% | |
| 0.6% | 0.5% | – | – | – | 81.8% | 87.4% | 28.9% | 30.2% | 25.8% | 24.3% | 23.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.